Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: CDC polio vaccine policy

Executive Summary

CDC polio vaccine policy: Centers for Disease Control & Prevention will change its polio vaccination policy to "include a greatly enhanced role for inactivated polio vaccine," CDC's Advisory Committee on Immunization Practices reports. The change is aimed at reducing the incidence of vaccine-associated paralytic polio, which is caused by oral live vaccine in roughly eight to 10 children per year. The new vaccination standard could be either an IPV-only regimen or some form of sequential or combination regimen including both IPV and oral live vaccine ("The Pink Sheet" June 26, T&G-7)...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS026483

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel